Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
β-GLUCAN COMPOSITION AND USE THEREFOR
Document Type and Number:
WIPO Patent Application WO/2020/249133
Kind Code:
A1
Abstract:
A β-glucan composition and a use therefor. Specifically provided are uses of the β-glucan composition in preparing a composition for improving or treating immune-related diseases, said β-glucan being a β-glucan containing β-1,3 and β-1,6 glucosidic bonds in the molecules thereof, and having a molecular weight of 1-50 kDa. The β-glucan features a novel structure, a controllable mass, abundant sources, simple preparation processing, high product purity, strong biological activity, and is easy to produce industrially, among other strengths. The resulting water-soluble β-glucan composition features better anti-tumor activity, has the potential to be developed into a safe and effective novel drug for improving or treating immune-related diseases and fighting tumors.

Inventors:
YU GUANGLI (CN)
LV YOUJING (CN)
QU XIANJUN (CN)
ZHAO CHENYANG (CN)
HAO JIEJIE (CN)
LI QUANCAI (CN)
ZHAO XIA (CN)
HU TING (CN)
GUAN HUASHI (CN)
Application Number:
PCT/CN2020/096224
Publication Date:
December 17, 2020
Filing Date:
June 15, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MARINE BIOMEDICAL RES INST QINGDAO CO LTD (CN)
International Classes:
C08B37/02; A23L33/26; A61K31/716; A61P35/00; A61P37/04
Foreign References:
CN105001352A2015-10-28
CN108430479A2018-08-21
CN109793752A2019-05-24
Other References:
BOBADILLA F. ET AL.: "Solubleβ-1, 3/1, 6-glucan in Seaweed from the Southern Hemisphere and its Immunomodulatory Effect.", CARBOHYDRATE POLYMERS, vol. 92, no. 1, 4 October 2012 (2012-10-04), pages 241 - 248, XP055347452
JIN, YIMING ET AL.: "Research Progress on β-Glucan and Its Development Potential in Health Industry", FOOD AND DRUG, vol. 20, no. 5, 20 September 2018 (2018-09-20), pages 377 - 381, XP055765383
See also references of EP 3985030A4
Attorney, Agent or Firm:
XU & PARTNERS, LLC. (CN)
Download PDF: